Japan approves first embolic beads for HCC
This article was originally published in Clinica
Executive Summary
An early 2009 Japanese government request for the development of embolic microbead therapies for the treatment of serious cancers has finally been answered more than four years later with the approval of Biocompatibles' DC Bead.